Connect with us

Business

Noromega Aims to Replicate China’s Success in Thailand Market

Editorial

Published

on

Noromega, a Norwegian health supplement brand, is set to expand its presence in Thailand, aiming to replicate its successful growth in China. Since entering the Chinese market through cross-border e-commerce in 2018, Noromega achieved cumulative sales of USD 100 million last year. The company’s CEO, Derek Liu, attributes this rapid growth largely to the diversification of its sales channels, particularly through livestreaming platforms.

During the Vitafoods Asia 2025 event in Bangkok, Liu emphasized the importance of maximizing sales avenues in China, a market rich with opportunities. “We wanted to expand to as many sales channels as possible because the Chinese market is so big, and there are so many different channels, such as e-commerce platforms like Tmall and social commerce platforms like Douyin,” he explained. The brand’s strategy also included offline retail, highlighting partnerships with popular membership-only supermarkets like Sam’s Club, which operates over 100 outlets in China.

The company has focused on consumer education to increase awareness of health supplements in a market where it remains relatively low. Liu noted that while young consumers are drawn to gummies “for fun,” older consumers typically stick to generic vitamins. Noromega offers a portfolio of more than 20 products, yet its marketing strategy in China has concentrated on a select few, particularly its astaxanthin and omega supplements. Liu pointed out that astaxanthin has become a top seller due to effective livestreaming campaigns showcasing its benefits for skin health.

Strategic Expansion Plans in Thailand

Currently, 80% of Noromega’s revenue in Asia is derived from China, a crucial factor in the company’s ability to invest in new markets. “Our investment fund comes from revenue in China. We have to ensure stable revenue so we can keep investing in other markets,” Liu stated. The brand is now targeting Thailand, Singapore, and Malaysia for further expansion, with Thailand being particularly appealing due to its similarities with the Chinese market.

Liu highlighted that while cultural and spending habits differ slightly, both markets share commonalities such as a variety of sales channels, including pharmacies and supermarkets. “The biggest similarity is the proliferation of e-commerce—Thai consumers use Lazada and Shopee like how Chinese consumers use Tmall and JD.com,” he noted. Additionally, the popularity of social media platforms like TikTok and Instagram in Thailand mirrors that of Douyin and RED in China, providing another avenue for marketing.

Liu expressed confidence in the Thai market, suggesting that local consumers are more informed about supplements and their benefits compared to their Chinese counterparts. At the Vitafoods Asia event, Noromega actively sought distributors to facilitate its entry into Thailand. The response from potential customers, distributors, and influencers has been overwhelmingly positive, indicating strong interest in the brand’s offerings.

As Noromega embarks on this new chapter, the company looks to leverage its successful strategies from China to establish a significant foothold in Thailand, opening up new opportunities in the rapidly growing health supplement sector.

Our Editorial team doesn’t just report the news—we live it. Backed by years of frontline experience, we hunt down the facts, verify them to the letter, and deliver the stories that shape our world. Fueled by integrity and a keen eye for nuance, we tackle politics, culture, and technology with incisive analysis. When the headlines change by the minute, you can count on us to cut through the noise and serve you clarity on a silver platter.

Continue Reading

Trending

Copyright © All rights reserved. This website offers general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information provided. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult relevant experts when necessary. We are not responsible for any loss or inconvenience resulting from the use of the information on this site.